Silverback Therapeutics, Inc. (NASDAQ:SBTX – Get Free Report) hit a new 52-week high during trading on Wednesday . The stock traded as high as $14.32 and last traded at $14.05, with a volume of 1130767 shares traded. The stock had previously closed at $13.05.
Silverback Therapeutics Trading Up 7.7 %
The firm has a market capitalization of $506.61 million, a P/E ratio of -5.81 and a beta of 0.60. The company’s fifty day simple moving average is $11.69 and its 200 day simple moving average is $9.89.
About Silverback Therapeutics
Silverback Therapeutics, Inc, a biopharmaceutical company, develops tissue-targeted therapeutics for the treatment of chronic viral infections, cancer, and other serious diseases. The company offers SBT8230 to treat chronic hepatitis B virus infection by eliciting an anti-viral immune response by targeting TLR8 activation to the liver.
Featured Stories
- Five stocks we like better than Silverback Therapeutics
- Stock Analyst Ratings and Canadian Analyst Ratings
- How Much Can You Make in Stocks in One Month?
- Biggest Stock Losers – Today’s Biggest Percentage Decliners
- This Is the Top Large-Cap Stock Insiders Are Buying
- Using the MarketBeat Dividend Yield Calculator
- Capitalize on Micron’s 24% Drop—Wall Street Eyes Major Upside
Receive News & Ratings for Silverback Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Silverback Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.
